{"transactions":[{"id":1306765,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-01-08T18:43:26.000Z","date":"2025-01-08","kind":"exercise","planned":false,"acquired":false,"shares":89292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit award will vest as to 25% of the underlying shares on January 8, 2025 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit award will vest as to 25% of the underlying shares on January 8, 2025 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters."}],"balance_after":267876,"derivative":{"underlying":"Class A Common Stock","underlying_shares":89292},"source":{"system":"sec-edgar","filing":"0001809519-25-000008","document":"wk-form4_1736379800.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951925000008/wk-form4_1736379800.xml","form_type":"4"}},{"id":1306764,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-01-08T18:43:26.000Z","date":"2025-01-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":29035,"price":4.41,"value":128044.35,"ownership":{"direct":true},"balance_after":363561,"source":{"system":"sec-edgar","filing":"0001809519-25-000008","document":"wk-form4_1736379800.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951925000008/wk-form4_1736379800.xml","form_type":"4"}},{"id":1306763,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-01-08T18:43:26.000Z","date":"2025-01-08","kind":"exercise","planned":false,"acquired":true,"shares":89292,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."}],"balance_after":392596,"source":{"system":"sec-edgar","filing":"0001809519-25-000008","document":"wk-form4_1736379800.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951925000008/wk-form4_1736379800.xml","form_type":"4"}},{"id":1339118,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-12-09T18:39:20.000Z","date":"2024-12-08","kind":"exercise","planned":false,"acquired":false,"shares":54064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters."}],"balance_after":378448,"derivative":{"underlying":"Class A Common Stock","underlying_shares":54064},"source":{"system":"sec-edgar","filing":"0001809519-24-000208","document":"wk-form4_1733787554.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951924000208/wk-form4_1733787554.xml","form_type":"4"}},{"id":1339117,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-12-09T18:39:20.000Z","date":"2024-12-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":24659,"price":4.91,"value":121075.69,"ownership":{"direct":true},"balance_after":303304,"source":{"system":"sec-edgar","filing":"0001809519-24-000208","document":"wk-form4_1733787554.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951924000208/wk-form4_1733787554.xml","form_type":"4"}},{"id":1339116,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-12-09T18:39:20.000Z","date":"2024-12-08","kind":"exercise","planned":false,"acquired":true,"shares":54064,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."}],"balance_after":327963,"source":{"system":"sec-edgar","filing":"0001809519-24-000208","document":"wk-form4_1733787554.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951924000208/wk-form4_1733787554.xml","form_type":"4"}},{"id":1411901,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-09-09T19:59:54.000Z","date":"2024-09-08","kind":"exercise","planned":false,"acquired":false,"shares":54064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters."}],"balance_after":432512,"derivative":{"underlying":"Class A Common Stock","underlying_shares":54064},"source":{"system":"sec-edgar","filing":"0001809519-24-000177","document":"wk-form4_1725926387.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951924000177/wk-form4_1725926387.xml","form_type":"4"}},{"id":1411900,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-09-09T19:59:54.000Z","date":"2024-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":24700,"price":7.71,"value":190437.0,"ownership":{"direct":true},"balance_after":273899,"source":{"system":"sec-edgar","filing":"0001809519-24-000177","document":"wk-form4_1725926387.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951924000177/wk-form4_1725926387.xml","form_type":"4"}},{"id":1411899,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-09-09T19:59:54.000Z","date":"2024-09-08","kind":"exercise","planned":false,"acquired":true,"shares":54064,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."}],"balance_after":298599,"source":{"system":"sec-edgar","filing":"0001809519-24-000177","document":"wk-form4_1725926387.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951924000177/wk-form4_1725926387.xml","form_type":"4"}},{"id":1485107,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-06-10T18:58:11.000Z","date":"2024-06-08","kind":"exercise","planned":false,"acquired":false,"shares":54064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters."}],"balance_after":486576,"derivative":{"underlying":"Class A Common Stock","underlying_shares":54064},"source":{"system":"sec-edgar","filing":"0001809519-24-000106","document":"wk-form4_1718060284.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951924000106/wk-form4_1718060284.xml","form_type":"4"}},{"id":1485106,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-06-10T18:58:11.000Z","date":"2024-06-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":21481,"price":8.55,"value":183662.55,"ownership":{"direct":true},"balance_after":244535,"source":{"system":"sec-edgar","filing":"0001809519-24-000106","document":"wk-form4_1718060284.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951924000106/wk-form4_1718060284.xml","form_type":"4"}},{"id":1485105,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-06-10T18:58:11.000Z","date":"2024-06-08","kind":"exercise","planned":false,"acquired":true,"shares":54064,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."}],"balance_after":266016,"source":{"system":"sec-edgar","filing":"0001809519-24-000106","document":"wk-form4_1718060284.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951924000106/wk-form4_1718060284.xml","form_type":"4"}},{"id":1576897,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-14T17:12:17.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":515793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option will vest and become exercisable as to 25% of the underlying shares on January 8, 2025 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters."}],"balance_after":515793,"derivative":{"exercise_price":7.22,"expiration_date":"2034-03-12","underlying":"Class A Common Stock","underlying_shares":515793},"source":{"system":"sec-edgar","filing":"0001809519-24-000049","document":"wk-form4_1710450723.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951924000049/wk-form4_1710450723.xml","form_type":"4"}},{"id":1576896,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-03-14T17:12:17.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":357168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit award will vest as to 25% of the underlying shares on January 8, 2025 with the remaining 75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit award will vest as to 25% of the underlying shares on January 8, 2025 with the remaining 75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters."}],"balance_after":357168,"derivative":{"underlying":"Class A Common Stock","underlying_shares":357168},"source":{"system":"sec-edgar","filing":"0001809519-24-000049","document":"wk-form4_1710450723.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951924000049/wk-form4_1710450723.xml","form_type":"4"}},{"id":1586995,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-03-08T17:14:29.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":false,"shares":54064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters."}],"balance_after":540640,"derivative":{"underlying":"Class A Common Stock","underlying_shares":54064},"source":{"system":"sec-edgar","filing":"0001809519-24-000043","document":"wk-form4_1709936058.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951924000043/wk-form4_1709936058.xml","form_type":"4"}},{"id":1586994,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-08T17:14:29.000Z","date":"2024-03-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":17240,"price":7.54,"value":129989.6,"ownership":{"direct":true},"balance_after":211952,"source":{"system":"sec-edgar","filing":"0001809519-24-000043","document":"wk-form4_1709936058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951924000043/wk-form4_1709936058.xml","form_type":"4"}},{"id":1586993,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-08T17:14:29.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":true,"shares":54064,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."}],"balance_after":229192,"source":{"system":"sec-edgar","filing":"0001809519-24-000043","document":"wk-form4_1709936058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951924000043/wk-form4_1709936058.xml","form_type":"4"}},{"id":1718005,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-12-08T17:18:57.000Z","date":"2023-12-08","kind":"exercise","planned":false,"acquired":false,"shares":54064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters."}],"balance_after":594704,"derivative":{"underlying":"Class A Common Stock","underlying_shares":54064},"source":{"system":"sec-edgar","filing":"0001809519-23-000057","document":"wk-form4_1702073926.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951923000057/wk-form4_1702073926.xml","form_type":"4"}},{"id":1718004,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-08T17:18:57.000Z","date":"2023-12-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":24757,"price":5.94,"value":147056.58,"ownership":{"direct":true},"balance_after":175128,"source":{"system":"sec-edgar","filing":"0001809519-23-000057","document":"wk-form4_1702073926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951923000057/wk-form4_1702073926.xml","form_type":"4"}},{"id":1718003,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-08T17:18:57.000Z","date":"2023-12-08","kind":"exercise","planned":false,"acquired":true,"shares":54064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."}],"balance_after":199885,"source":{"system":"sec-edgar","filing":"0001809519-23-000057","document":"wk-form4_1702073926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951923000057/wk-form4_1702073926.xml","form_type":"4"}},{"id":1784790,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-09-08T17:26:02.000Z","date":"2023-09-08","kind":"exercise","planned":false,"acquired":false,"shares":54064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters."}],"balance_after":648768,"derivative":{"underlying":"Class A Common Stock","underlying_shares":54064},"source":{"system":"sec-edgar","filing":"0001809519-23-000008","document":"wk-form4_1694208351.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951923000008/wk-form4_1694208351.xml","form_type":"4"}},{"id":1784789,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-09-08T17:26:02.000Z","date":"2023-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":19757,"price":6.16,"value":121703.12,"ownership":{"direct":true},"balance_after":145821,"source":{"system":"sec-edgar","filing":"0001809519-23-000008","document":"wk-form4_1694208351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951923000008/wk-form4_1694208351.xml","form_type":"4"}},{"id":1784788,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-09-08T17:26:02.000Z","date":"2023-09-08","kind":"exercise","planned":false,"acquired":true,"shares":54064,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."}],"balance_after":165578,"source":{"system":"sec-edgar","filing":"0001809519-23-000008","document":"wk-form4_1694208351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000180951923000008/wk-form4_1694208351.xml","form_type":"4"}},{"id":1858978,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-06-12T21:33:19.000Z","date":"2023-06-08","kind":"exercise","planned":false,"acquired":false,"shares":54064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters."}],"balance_after":702832,"derivative":{"underlying":"Class A Common Stock","underlying_shares":54064},"source":{"system":"sec-edgar","filing":"0000950170-23-027562","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000095017023027562/ownership.xml","form_type":"4"}},{"id":1858977,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-12T21:33:19.000Z","date":"2023-06-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":16611,"price":5.41,"value":89865.51,"ownership":{"direct":true},"balance_after":111514,"source":{"system":"sec-edgar","filing":"0000950170-23-027562","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000095017023027562/ownership.xml","form_type":"4"}},{"id":1858976,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-06-12T21:33:19.000Z","date":"2023-06-08","kind":"exercise","planned":false,"acquired":true,"shares":54064,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."}],"balance_after":128125,"source":{"system":"sec-edgar","filing":"0000950170-23-027562","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000095017023027562/ownership.xml","form_type":"4"}},{"id":1961193,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-03-09T19:59:12.000Z","date":"2023-03-08","kind":"exercise","acquired":false,"shares":54064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters."}],"balance_after":756896,"derivative":{"underlying":"Class A Common Stock","underlying_shares":54064},"source":{"system":"sec-edgar","filing":"0000899243-23-007790","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924323007790/doc4.xml","form_type":"4"}},{"id":1961192,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-09T19:59:12.000Z","date":"2023-03-08","kind":"tax_withholding","acquired":false,"shares":17397,"price":5.5,"value":95683.5,"ownership":{"direct":true},"balance_after":74061,"source":{"system":"sec-edgar","filing":"0000899243-23-007790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924323007790/doc4.xml","form_type":"4"}},{"id":1961191,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-09T19:59:12.000Z","date":"2023-03-08","kind":"exercise","acquired":true,"shares":54064,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."}],"balance_after":91458,"source":{"system":"sec-edgar","filing":"0000899243-23-007790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924323007790/doc4.xml","form_type":"4"}},{"id":2089852,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-12-12T17:24:36.000Z","date":"2022-12-08","kind":"exercise","acquired":false,"shares":54063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% to vest in approximately equal quarterly installments thereafter for 15 quarters."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% to vest in approximately equal quarterly installments thereafter for 15 quarters."}],"balance_after":810960,"derivative":{"underlying":"Class A Common Stock","underlying_shares":54063},"source":{"system":"sec-edgar","filing":"0000899243-22-038253","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924322038253/doc4.xml","form_type":"4"}},{"id":2089851,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-12T17:24:36.000Z","date":"2022-12-08","kind":"tax_withholding","acquired":false,"shares":16669,"price":4.98,"value":83011.62,"ownership":{"direct":true},"balance_after":37394,"source":{"system":"sec-edgar","filing":"0000899243-22-038253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924322038253/doc4.xml","form_type":"4"}},{"id":2089850,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-12T17:24:36.000Z","date":"2022-12-08","kind":"exercise","acquired":true,"shares":54063,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."}],"balance_after":54063,"source":{"system":"sec-edgar","filing":"0000899243-22-038253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924322038253/doc4.xml","form_type":"4"}},{"id":2151306,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-09-26T16:47:02.000Z","date":"2022-09-22","kind":"grant","acquired":true,"shares":865023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit award vests as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% to vest in approximately equal quarterly installments thereafter for 15 quarters."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit award vests as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% to vest in approximately equal quarterly installments thereafter for 15 quarters."}],"balance_after":865023,"derivative":{"underlying":"Class A Common Stock","underlying_shares":865023},"source":{"system":"sec-edgar","filing":"0000899243-22-032043","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924322032043/doc4.xml","form_type":"4"}},{"id":2456277,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-30T16:30:11.000Z","date":"2021-12-28","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on March 2, 2020."}],"balance_after":342500,"derivative":{"exercise_price":6.84,"expiration_date":"2030-03-26","underlying":"Class A Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-21-050104","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321050104/doc4.xml","form_type":"4"}},{"id":2456276,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-30T16:30:11.000Z","date":"2021-12-28","kind":"sale","acquired":false,"shares":12500,"price":33.0546,"value":413182.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020, as amended on August 27, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.31. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-050104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321050104/doc4.xml","form_type":"4"}},{"id":2456275,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-30T16:30:11.000Z","date":"2021-12-28","kind":"exercise","acquired":true,"shares":12500,"price":6.84,"value":85500.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0000899243-21-050104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321050104/doc4.xml","form_type":"4"}},{"id":2486308,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-03T16:22:18.000Z","date":"2021-12-01","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on March 2, 2020."}],"balance_after":355000,"derivative":{"exercise_price":6.84,"expiration_date":"2030-03-26","underlying":"Class A Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-21-046781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321046781/doc4.xml","form_type":"4"}},{"id":2486307,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-03T16:22:18.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":6111,"price":40.2198,"value":245783.1978,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020, as amended on August 27, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.91 to $40.55. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-046781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321046781/doc4.xml","form_type":"4"}},{"id":2486306,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-03T16:22:18.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":2200,"price":39.3068,"value":86474.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020, as amended on August 27, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.86 to $39.81. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":6111,"source":{"system":"sec-edgar","filing":"0000899243-21-046781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321046781/doc4.xml","form_type":"4"}},{"id":2486305,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-03T16:22:18.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":4189,"price":38.3496,"value":160646.4744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020, as amended on August 27, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.82 to $38.80. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8311,"source":{"system":"sec-edgar","filing":"0000899243-21-046781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321046781/doc4.xml","form_type":"4"}},{"id":2486304,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-03T16:22:18.000Z","date":"2021-12-01","kind":"exercise","acquired":true,"shares":12500,"price":6.84,"value":85500.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0000899243-21-046781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321046781/doc4.xml","form_type":"4"}},{"id":2526599,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-03T20:32:27.000Z","date":"2021-11-01","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on March 2, 2020."}],"balance_after":367500,"derivative":{"exercise_price":6.84,"expiration_date":"2030-03-26","underlying":"Class A Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-21-042900","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321042900/doc4.xml","form_type":"4"}},{"id":2526598,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-03T20:32:27.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020, as amended on August 27, 2021"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-042900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321042900/doc4.xml","form_type":"4"}},{"id":2526597,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-03T20:32:27.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":12300,"price":44.0374,"value":541660.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020, as amended on August 27, 2021"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.66 to $44.61. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0000899243-21-042900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321042900/doc4.xml","form_type":"4"}},{"id":2526596,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-03T20:32:27.000Z","date":"2021-11-01","kind":"exercise","acquired":true,"shares":12500,"price":6.84,"value":85500.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0000899243-21-042900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321042900/doc4.xml","form_type":"4"}},{"id":2556780,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-29T21:13:30.000Z","date":"2021-09-28","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on March 2, 2020."}],"balance_after":380000,"derivative":{"exercise_price":6.84,"expiration_date":"2030-03-26","underlying":"Class A Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000899243-21-038251","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321038251/doc4.xml","form_type":"4"}},{"id":2556779,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-29T21:13:30.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":500,"price":41.516,"value":20758.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020, as amended on August 27, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.99 to $41.96. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-038251","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321038251/doc4.xml","form_type":"4"}},{"id":2556778,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-29T21:13:30.000Z","date":"2021-09-28","kind":"sale","acquired":false,"shares":7000,"price":40.2198,"value":281538.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020, as amended on August 27, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.87 to $40.70. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0000899243-21-038251","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321038251/doc4.xml","form_type":"4"}},{"id":2556777,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-29T21:13:30.000Z","date":"2021-09-28","kind":"exercise","acquired":true,"shares":7500,"price":6.84,"value":51300.0,"ownership":{"direct":true},"balance_after":7500,"source":{"system":"sec-edgar","filing":"0000899243-21-038251","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321038251/doc4.xml","form_type":"4"}},{"id":2583822,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-01T16:05:16.000Z","date":"2021-08-30","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on March 2, 2020."}],"balance_after":387500,"derivative":{"exercise_price":6.84,"expiration_date":"2030-03-26","underlying":"Class A Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-21-034726","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321034726/doc4.xml","form_type":"4"}},{"id":2583821,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-01T16:05:16.000Z","date":"2021-08-30","kind":"sale","acquired":false,"shares":100,"price":37.71,"value":3771.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-034726","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321034726/doc4.xml","form_type":"4"}},{"id":2583820,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-01T16:05:16.000Z","date":"2021-08-30","kind":"sale","acquired":false,"shares":12400,"price":36.9965,"value":458756.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.69 to $37.64. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0000899243-21-034726","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321034726/doc4.xml","form_type":"4"}},{"id":2583819,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-01T16:05:16.000Z","date":"2021-08-30","kind":"exercise","acquired":true,"shares":12500,"price":6.84,"value":85500.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0000899243-21-034726","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321034726/doc4.xml","form_type":"4"}},{"id":2621393,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-30T18:01:17.000Z","date":"2021-07-28","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on March 2, 2020."}],"balance_after":400000,"derivative":{"exercise_price":6.84,"expiration_date":"2030-03-26","underlying":"Class A Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-21-030851","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321030851/doc4.xml","form_type":"4"}},{"id":2621392,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-30T18:01:17.000Z","date":"2021-07-28","kind":"sale","acquired":false,"shares":7842,"price":32.9167,"value":258132.7614,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.80 to $33.01. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-030851","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321030851/doc4.xml","form_type":"4"}},{"id":2621391,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-30T18:01:17.000Z","date":"2021-07-28","kind":"sale","acquired":false,"shares":4658,"price":32.4635,"value":151214.983,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.80 to $32.79. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7842,"source":{"system":"sec-edgar","filing":"0000899243-21-030851","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321030851/doc4.xml","form_type":"4"}},{"id":2621390,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-30T18:01:17.000Z","date":"2021-07-28","kind":"exercise","acquired":true,"shares":12500,"price":6.84,"value":85500.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0000899243-21-030851","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321030851/doc4.xml","form_type":"4"}},{"id":2650431,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-30T16:35:06.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on March 2, 2020."}],"balance_after":412500,"derivative":{"exercise_price":6.84,"expiration_date":"2030-03-26","underlying":"Class A Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-21-026752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321026752/doc4.xml","form_type":"4"}},{"id":2650430,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-30T16:35:06.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":12500,"price":37.3729,"value":467161.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into as of November 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.02 to $37.94. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-026752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321026752/doc4.xml","form_type":"4"}},{"id":2650429,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-30T16:35:06.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":12500,"price":6.84,"value":85500.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0000899243-21-026752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321026752/doc4.xml","form_type":"4"}},{"id":2686944,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-02T18:25:45.000Z","date":"2021-05-28","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on March 2, 2020."}],"balance_after":425000,"derivative":{"exercise_price":6.84,"expiration_date":"2030-03-26","underlying":"Class A Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-21-021633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321021633/doc4.xml","form_type":"4"}},{"id":2686943,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-02T18:25:45.000Z","date":"2021-05-28","kind":"sale","acquired":false,"shares":250,"price":39.09,"value":9772.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price reported in Column 4 is a werighted average price. These shares were sold in multiple transactions at prices ranging from $39.05 to $39.14. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-021633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321021633/doc4.xml","form_type":"4"}},{"id":2686942,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-02T18:25:45.000Z","date":"2021-05-28","kind":"sale","acquired":false,"shares":4281,"price":38.5838,"value":165177.2478,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price reported in Column 4 is a werighted average price. These shares were sold in multiple transactions at prices ranging from $38.05 to $39.01. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":250,"source":{"system":"sec-edgar","filing":"0000899243-21-021633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321021633/doc4.xml","form_type":"4"}},{"id":2686941,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-02T18:25:45.000Z","date":"2021-05-28","kind":"sale","acquired":false,"shares":7969,"price":37.4945,"value":298793.6705,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.03 to $38.02. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":4531,"source":{"system":"sec-edgar","filing":"0000899243-21-021633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321021633/doc4.xml","form_type":"4"}},{"id":2686940,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-06-02T18:25:45.000Z","date":"2021-05-28","kind":"exercise","acquired":true,"shares":12500,"price":6.84,"value":85500.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0000899243-21-021633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321021633/doc4.xml","form_type":"4"}},{"id":2734674,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-30T16:05:16.000Z","date":"2021-04-28","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on March 2, 2020."}],"balance_after":437500,"derivative":{"exercise_price":6.84,"expiration_date":"2030-03-26","underlying":"Class A Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-21-017622","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321017622/doc4.xml","form_type":"4"}},{"id":2734673,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-04-30T16:05:16.000Z","date":"2021-04-28","kind":"sale","acquired":false,"shares":501,"price":41.0529,"value":20567.5029,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price reported in Column 4 is a werighted average price. These shares were sold in multiple transactions at prices ranging from $41.02 to $41.11. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-017622","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321017622/doc4.xml","form_type":"4"}},{"id":2734672,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-04-30T16:05:16.000Z","date":"2021-04-28","kind":"sale","acquired":false,"shares":11999,"price":40.2187,"value":482584.1813,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.95 to $40.94. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":501,"source":{"system":"sec-edgar","filing":"0000899243-21-017622","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321017622/doc4.xml","form_type":"4"}},{"id":2734671,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-04-30T16:05:16.000Z","date":"2021-04-28","kind":"exercise","acquired":true,"shares":12500,"price":6.84,"value":85500.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0000899243-21-017622","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321017622/doc4.xml","form_type":"4"}},{"id":2766629,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-31T16:15:17.000Z","date":"2021-03-29","kind":"exercise","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on March 2, 2020"}],"balance_after":450000,"derivative":{"exercise_price":6.84,"expiration_date":"2030-03-26","underlying":"Class A Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-21-014167","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321014167/doc4.xml","form_type":"4"}},{"id":2766628,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-03-31T16:15:17.000Z","date":"2021-03-29","kind":"sale","acquired":false,"shares":100,"price":38.54,"value":3854.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-014167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321014167/doc4.xml","form_type":"4"}},{"id":2766627,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-03-31T16:15:17.000Z","date":"2021-03-29","kind":"sale","acquired":false,"shares":47469,"price":37.7232,"value":1790682.5808,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.49 to 36.465. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0000899243-21-014167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321014167/doc4.xml","form_type":"4"}},{"id":2766626,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-03-31T16:15:17.000Z","date":"2021-03-29","kind":"sale","acquired":false,"shares":102431,"price":37.0299,"value":3793009.6869,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.49 to $37.47. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":47569,"source":{"system":"sec-edgar","filing":"0000899243-21-014167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321014167/doc4.xml","form_type":"4"}},{"id":2766625,"issuer":{"id":4838,"kind":"organization","name":"GoodRx Holdings, Inc.","symbol":"GDRX"},"owners":[{"id":84291,"kind":"person","name":"Voermann Karsten","position":1,"cik":"0001822140","reported_name":"Voermann Karsten","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-03-31T16:15:17.000Z","date":"2021-03-29","kind":"exercise","acquired":true,"shares":150000,"price":6.84,"value":1026000.0,"ownership":{"direct":true},"balance_after":150000,"source":{"system":"sec-edgar","filing":"0000899243-21-014167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1822140/000089924321014167/doc4.xml","form_type":"4"}}]}